NBSE NASDAQ
NeuBase Therapeutics, Inc.
1W: +0.0%
1M: -14.5%
3M: -59.0%
1Y: -90.5%
3Y: -99.6%
5Y: -99.3%
$0.38
Last traded 2024-05-24 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-14M
Net Income
+59.4% YoY
$-15M
Free Cash Flow
+49.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-84.9%
ROA-53.5%
ROIC-634.2%
Valuation
P/E-0.0
P/B0.0
EV/EBITDA0.6
Leverage
Debt/Equity0.58
Current Ratio2.87
Interest Cov.-2705.0x
Quality Scores
Piotroski F2/9
Altman Z-10.63
Beneish M0.00